NCT06726941 Effect of Exercise Gene Expression and Histone Modifications in Patients With Hemiplegia
| NCT ID | NCT06726941 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Afyonkarahisar Health Sciences University |
| Condition | Ischemic Stroke, Acute |
| Study Type | INTERVENTIONAL |
| Enrollment | 48 participants |
| Start Date | 2024-12-20 |
| Primary Completion | 2026-06-09 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 48 participants in total. It began in 2024-12-20 with a primary completion date of 2026-06-09.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
The aim of this study is to demonstrate the effect of routine exercise program on neuroplasticity through histone acetylation and gene expression changes in acute stroke survivors from an epigenetic perspective and to investigate the correlation of epigenetic effects with its effects on motor function and quality of life.
Eligibility Criteria
Inclusion Criteria: 1. Participants who applied to Afyonkarahisar Health Sciences University Physical Therapy and Rehabilitation Clinic for rehabilitation purposes and had a stroke for the first time 2. Participants with ischemia as the etiology of stroke 3. Participants between the ages of 25-70 4. Drugs that have been used for at least 1 month and up to 6 months after a cerebrovascular accident Exclusion Criteria: 1. Participants whose stroke etiology is other than ischemia 2. Participants with clinically significant neurological disease other than stroke 3. Participants with systemic and musculoskeletal diseases that will not tolerate neurological rehabilitation and prevent them from participating
Contact & Investigator
Hasan Toktas, Professor
PRINCIPAL INVESTIGATOR
Afyonkarahisar Health Sciences University
Frequently Asked Questions
Who can join the NCT06726941 clinical trial?
This trial is open to participants of all sexes, aged 25 Years or older, up to 70 Years, studying Ischemic Stroke, Acute. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT06726941 currently recruiting?
Yes, NCT06726941 is actively recruiting participants. Contact the research team at hasantoktas@yahoo.com for enrollment information.
Where is the NCT06726941 trial being conducted?
This trial is being conducted at Afyonkarahisar, Turkey (Türkiye).
Who is sponsoring the NCT06726941 clinical trial?
NCT06726941 is sponsored by Afyonkarahisar Health Sciences University. The principal investigator is Hasan Toktas, Professor at Afyonkarahisar Health Sciences University. The trial plans to enroll 48 participants.
Related Trials
Related Intelligence Guides
In-depth guides covering this condition's trials, eligibility, and what to expect.